G1 Therapeutics, Inc.

G1 Therapeutics, Inc.

G1 Therapeutics, Inc.

Overview
Date Founded

2008

Headquarters

79 T.W. Alexander Drive,4501 Research Commons,Suite 100,Research Triangle Park, NC 27709

Type of Company

Public

Employees (Worldwide)

104

Industries

Pharmaceuticals
Medical Support Services
Holding Companies
Biotechnology

Company Description

G1 Therapeutics, Inc. engages in the development of small molecule therapeutics for the treatment of patients with cancer. Its products pipeline includes trilaciclib, rintodestrant, and lerociclib. The company was founded by Kwok-Kin Wong and Norman E. Sharpless on May 19, 2008 and is headquartered in Research Triangle Park, NC.

Contact Data
Trying to get in touch with decision makers at G1 Therapeutics, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

President & Chief Executive Officer

President

Chief Financial Officer

Chief Operating Officer

General Counsel

Chief Commercial Officer

Chief Business Officer

Chief Medical Officer, Senior Vice President-Research & Development

Vice President, Human Resources

Vice President, Investor Relations & Corporate Communications

Board of Directors

Former President & General Manager, Oncology Business Unit at Pfizer, Inc.

Former President, Manufacturing Division at Merck & Co., Inc.

Former Executive Vice President, Finance & Administration, Assistant Treasurer & Assistant Secretary at Hologic, Inc.

Chief Executive Officer at Innocrin Pharmaceuticals, Inc.

Former President & Chief Executive Officer at Ipsen Biopharmaceuticals, Inc.

Chief Financial & Business Officer at Entasis Therapeutics, Inc.

President & Chief Executive Officer at G1 Therapeutics, Inc.

Former Director at G1 Therapeutics, Inc.

Paths to G1 Therapeutics, Inc.
Potential Connections via
Relationship Science
You
G1 Therapeutics, Inc.
Owners & Shareholders
Details Hidden

MPM Oncology Impact Management LP, a subsidiary of MPM Capital LLC, is an American company located in Cambridge, MA, that provides investment advice.

Details Hidden

BCM focuses on long/short investments in the health care industry. Their investment process is driven by deep medical research and clinical insight. The firm seeks to invest in undervalued companies which are developing compelling drugs, medical technologies, research tools, and diagnostics.

Details Hidden

361C employs multiple methodologies while managing their various strategies. Their approaches are rooted in behavioral finance, attempting to exploit market inefficiencies. For their long-only equity strategies, their proprietary quantitative models attempt to identify companies that are believed to be poised for attractive relative price appreciation. The firm generally evaluates each company within a defined universe with respect to relative trading liquidity, price performance, security analyst behavior, earnings estimates, security valuations, surprise earnings announcements, earnings quality, and other fundamental characteristics.

Recent Transactions
Details Hidden

G1 Therapeutics, Inc. issued USD Common Stock

Details Hidden

G1 Therapeutics, Inc. issued USD Common Stock

Details Hidden

G1 Therapeutics, Inc. issued USD Common Stock

Insider Transactions
Details Hidden
Details Hidden
Details Hidden
Transaction Advisors
Escrow Agent

Advised onG1 Therapeutics, Inc. issued USD Common Stock

Underwriter

Advised onG1 Therapeutics, Inc. issued USD Common Stock

Underwriter

Advised onG1 Therapeutics, Inc. issued USD Common Stock

Legal Advisor

Advised onG1 Therapeutics, Inc. issued USD Common Stock

Chair of the Securities Practice Group

Advised onG1 Therapeutics, Inc. issued USD Common Stock

Associate

Advised onG1 Therapeutics, Inc. issued USD Common Stock

Advisors & Consultants
Advisor

Director & Quick Family Chair-Center for Sarcoma & Bone Oncology at Dana-Farber Cancer Institute, Inc.

Advisor

Former Vice Chairman at Cancer Prevention & Research Institute of Texas

Advisor
Key Stats and Financials As of 2019
Market Capitalization
$684M
Total Enterprise Value
$732M
Earnings Per Share
$-3.27
Revenue
$0
EBITDA
$-129M
Total Debt
$10.2M
Total Equity
$256M
Net Profit
$-122M
TEVNet Income
-5.98x
Debt TEV
0.01x
Three Year Compounded Annual Growth Rate Of Revenue
0%
Five Year Compounded Annual Growth Rate Of Revenue
-100%
Investors
Details Hidden

Aju IB is a long-term investor focused on high technology Korean companies with significant growth potential.Aju IB's investment criteria include management's capability, ethics and transparency, potential market leadership or ability to control the market, technological barriers to entry, significant market size, profitability and maturity. They also take into consideration portfolio diversification.

Details Hidden

Cormorant invests in companies primarily located in North America. The firm targets companies in sectors such as life-science and biotech. It provides financing for early stage capital requirements.

Details Hidden

LUMIRA primarily focuses on later stage biopharmaceutical and medical device companies located in US and Canada. The firm partners with management teams and also invests in health IT and consumer health sectors.

Suppliers
University of Illinois Other Business & Consulting Services | Champaign, ILLINOIS

UIC is a major research university offering the cultural, business and entertainment opportunities you can only find in a world-class city. As one of the top 200 research-funded institutions in the world, UIC faculty discover the things that others teach. Choose from 15 academic colleges including the UIC College of Medicine-the largest in the nation-which educates one in six Illinois physicians. With nearly 2,574 instructional faculty members, there is one faculty member to every 11 students, which allows for a more personal learning experience. What's more, 75 percent of tenured faculty members teach undergraduate courses and 83 percent of full-time instructional faculty have earned a PhD or equivalent. But it's not all work and no play at UIC... Our 16,911 undergrads and 10,669 graduate and professional students make up one of the most diverse student bodies in the United States. Whether living in residence halls, near campus or commuting, you'll find there's always something interesting going on, from social events, clubs, sororities and fraternities, to two state-of-the-art fitness centers, and more-not to mention everything Chicago has to offer just minutes away. And at UIC, we take our sports seriously. The UIC Flames compete in 18 NCAA Division 1 sports and have won a total of 38 conference championships. There's a wide range of intramural teams and sports clubs for students to join.

Competitors
Rapt Therapeutics, Inc. Biotechnology - South San Francisco, CA

Rapt Therapeutics, Inc. operates as a clinical stage immunology-based biopharmaceutical company. It focuses on discovering, developing and commercializing oral small molecule therapies for patients in oncology and inflammatory diseases.. The company was founded in 2015 and is headquartered in South San Francisco, CA.

Roche Holding AG Pharmaceuticals - Basel, Switzerland

Roche Holding ag Roche Personalised Healthcare – our mission The healthcare landscape is constantly changing. Patients, physicians and payers demand safer, more effective treatments, while investors search after robust and sustainable business models. Growing demand for highly effective, impactful medicines is being driven by an aging population, healthcare and economic pressures. But an influx of new technologies enables Roche to meet this need by offering innovative tests and medicines. These healthcare drivers have led us in one direction – ‘Roche Personalised Healthcare’. At Roche, ‘Personalised Healthcare’ is at the core of our business strategy

Pfizer, Inc. Pharmaceuticals - New York, NY

Pfizer Inc. engages in the discovery, development, and manufacture of healthcare products specializes in medicines, vaccine, and consumer healthcare. It operates through the Pfizer Innovative Health (IH) and Pfizer Essential Health (EH) segments. The IH segment focuses on the development and commercializing medicines and vaccines for internal medicine, oncology, inflammation and immunology, rate disease, and consumer healthcare. The EH segment is involved in development and supply of branded generics, generic sterile injectable products, biosimilars, and select branded products including anti-infectives. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by G1 Therapeutics, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of G1 Therapeutics, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and G1 Therapeutics, Inc..